CEP68 Antibody

What is CEP68 and why is it important in cellular biology?

CEP68 is a centrosomal protein that plays a crucial role in centrosome cohesion during interphase. It decorates fibers emanating from the proximal ends of centrioles, forming part of the centrosome linker structure that connects the two centrosomes of a cell into a single microtubule-organizing center . CEP68 exists in two isoforms: a larger ~90 kDa form (CEP68L) and a smaller ~67 kDa form (CEP68S) . The protein is critical for maintaining genomic stability through proper centrosome function and cell division . Localization studies using super-resolution microscopy reveal that CEP68 forms a web-like filamentous network that originates at each centriole and radiates outward into the cytoplasm, exhibiting a highly ordered organization with a striated pattern .

What types of CEP68 antibodies are available for research applications?

Several types of CEP68 antibodies are commercially available, primarily polyclonal antibodies raised in rabbits. These antibodies vary in their epitope targets and validated applications:

For specific applications like super-resolution microscopy, researchers have generated custom antibodies against defined regions of CEP68, including the N-terminal fragment (amino acids 1-497) .

What are the recommended positive controls for validating CEP68 antibodies?

For Western blot applications, the following positive controls have been successfully used:

• Human cell lines: HeLa, COLO-320, SK-OV-3, and Jurkat whole cell lysates

• Tissue samples: Rat heart tissue, mouse heart tissue

• Isolated centrosomes from human KE37 T-lymphoblastoid cells

For immunofluorescence, U2OS and HeLaS3 cells have been successfully used to detect endogenous CEP68 . To confirm antibody specificity, siRNA-mediated depletion of CEP68 should eliminate the signal in both Western blot and immunofluorescence applications .

How should I optimize fixation and immunostaining protocols for CEP68 detection?

For optimal CEP68 immunostaining results, the following protocol has been validated:

• Grow cells on coverslips and wash once in PBS

• Fix cells in -20°C methanol for 10 minutes

• Wash coverslips in PBS and block in 1% bovine serum albumin (BSA) in PBS for 30 minutes

• Incubate with primary antibodies diluted in 3% BSA-PBS for 1 hour at room temperature

• Perform three washes in PBS, 10 minutes each

• Incubate with secondary antibodies (Alexa Fluor 488/555 or Cy2/Cy3-conjugated, 1:1000 dilution) for 1 hour

• Wash three times and mount using glycerol-based mounting medium containing p-phenylenediamine as an anti-fading agent

For co-staining experiments, CEP68 antibodies can be combined with centrosomal markers such as anti-γ-tubulin (1:1000), anti-α-tubulin (1:5000), or anti-C-Nap1 antibodies .

What high-resolution imaging techniques are most effective for visualizing CEP68 structures?

Several advanced imaging techniques have proven effective for visualizing CEP68 filamentous structures:

• STED (Stimulated Emission Depletion) Nanoscopy: This super-resolution technique reveals CEP68's web-like filamentous networks with a repeat organization of 75 nm, showing striated patterns indicating highly ordered protein organization .

• Deconvolution Fluorescence Microscopy: Using Deltavision deconvolution instruments, researchers have observed that CEP68 localizes to striking fibers originating from centrioles .

• Pre-embedding Immuno-Electron Microscopy: This technique demonstrates that CEP68-positive fibers are associated with the proximal ends of centrioles, with typically 2-4 fibers emanating from individual centrioles and extending beyond 0.5 μm in length .

For optimal results with these techniques, standard immunofluorescence protocols should be modified to maximize signal-to-noise ratio and preserve the delicate filamentous structures.

How can I quantitatively analyze CEP68 expression throughout the cell cycle?

For quantitative analysis of CEP68 levels during cell cycle progression:

• Synchronize cell populations using appropriate methods (double thymidine block, nocodazole arrest)

• Collect samples at defined time points representing different cell cycle stages

• Western blot analysis:

  • Prepare whole cell lysates from synchronized cells

  • Run samples on SDS-PAGE and transfer to membranes

  • Probe with anti-CEP68 antibodies

  • Include cell cycle markers (cyclin B1, phospho-histone H3) to confirm cell cycle stages

  • Quantify band intensities using image analysis software

• Immunofluorescence analysis:

  • Co-stain with DAPI and Lamin B to identify cell cycle phases

  • Quantify CEP68 fluorescence intensity at centrosomes using image analysis software

  • Compare intensities across different cell cycle stages

Research has shown that CEP68 levels are high in S and G2 cells, absent in prometaphase cells due to proteasomal degradation, and progressively increase through the next G1 phase .

How does CEP68 interact with other centrosomal proteins to maintain centrosome cohesion?

CEP68 functions within a complex network of proteins to maintain centrosome cohesion:

The C-terminal domain of CEP68 containing a spectrin repeat interacts specifically with the R3 subfragment of rootletin (amino acids 1,079 to 1,825) . This interaction is crucial for the formation and stability of the filamentous network that connects centrosomes. Depletion studies show that these proteins exhibit mutual dependency for proper localization, as summarized in the table below:

This interdependence demonstrates the complex structural relationships between these proteins in maintaining centrosome cohesion .

What is the mechanism of CEP68 regulation during mitosis?

CEP68 undergoes regulated degradation during mitosis through a multi-step process:

• Phosphorylation: PLK1 (Polo-like kinase 1) phosphorylates CEP68 at Serine 332 during early mitosis

• Recognition: This phosphorylation creates a phosphodegron recognized by SCF-βTrCP E3 ubiquitin ligase complexes

• Ubiquitination: SCF-βTrCP ubiquitinates CEP68, targeting it for proteasomal degradation

• Degradation: The ubiquitinated CEP68 is degraded by the 26S proteasome

This process is essential for proper centrosome separation during mitosis. Experimental evidence shows that:

• Inhibition of PLK1 with BI2536 prevents CEP68 downregulation in prometaphase cells

• MG132 (proteasome inhibitor) and MLN4924 (cullin-RING ligase inhibitor) prevent CEP68 degradation

• Mutation of Serine 332 to Alanine stabilizes CEP68 during mitosis

The degradation of CEP68 allows the removal of Cep215 from the peripheral pericentriolar material, which is necessary to prevent premature centriole separation following disengagement .

What is the functional significance of the spectrin repeat in CEP68?

The spectrin repeat at the C-terminus of CEP68 (amino acids 618 to 757) plays several critical roles:

• Centrosome Targeting: The C-terminal fragment containing the spectrin repeat binds to centrioles, similar to full-length CEP68, while the N-terminal fragment (amino acids 1 to 298) is diffusely distributed in cells .

• Rootletin Interaction: The spectrin repeat mediates interaction with the R3 subfragment of rootletin (amino acids 1,079 to 1,825). When this rootletin fragment is overexpressed, it recruits endogenous CEP68, indicating direct interaction .

• Filament Organization: The spectrin repeat likely contributes to the ordered organization of CEP68 within the centrosome linker, affecting the thickness of rootletin filaments and promoting filament formation from the rootletin ring that encircles C-Nap1 at centrioles .

This domain architecture is interesting because spectrin repeats are also present in Nesprin1, another rootletin binding partner, suggesting a conserved interaction mechanism between rootletin and its binding partners .

How can I use CEP68 antibodies to investigate centrosome cohesion defects?

To investigate centrosome cohesion defects using CEP68 antibodies:

• Baseline Assessment:

  • Immunostain control cells with CEP68 antibody and a centriole marker (γ-tubulin)

  • Measure intercentriolar distance in at least 100 cells

  • Classify as "paired" (<2 μm apart) or "split" (>2 μm apart)

• Experimental Manipulations:

  • Gene silencing: Transfect cells with siRNAs targeting proteins of interest

  • Drug treatments: Treat cells with kinase inhibitors or other compounds

  • Genetic modifications: Express mutant proteins or tagged constructs

• Analysis Methods:

  • Quantify the percentage of cells with split centrosomes

  • Measure changes in CEP68 localization patterns

  • Evaluate colocalization with other centrosomal proteins

This approach has revealed that depletion of CEP68 causes centrosome splitting, confirming its role in centrosome cohesion . Similar approaches can be used to identify novel regulators of centrosome cohesion or investigate the effects of disease-associated mutations.

How can CEP68 antibodies be used in cancer research applications?

CEP68 antibodies have several applications in cancer research:

• Centrosome Abnormality Assessment:

  • Immunostain cancer tissue samples for CEP68 and centrosomal markers

  • Quantify centrosome number, size, and cohesion status

  • Compare with normal tissue controls

  • Rationale: Centrosome abnormalities are common in many cancers and may contribute to chromosomal instability

• Cell Cycle Dysregulation Analysis:

  • Examine CEP68 degradation patterns in cancer cells

  • Evaluate PLK1 activity and regulation of CEP68 in different cancer types

  • Method: Synchronize cells and analyze CEP68 levels by Western blot and immunofluorescence

• Therapeutic Target Investigation:

  • Screen for compounds that affect CEP68 stability or function

  • Evaluate effects on cancer cell proliferation and survival

  • Rationale: Dysregulation of CEP68 has been implicated in various cancer types, highlighting its potential as a therapeutic target

• Biomarker Development:

  • Analyze CEP68 expression patterns in tissue microarrays

  • Correlate with clinical parameters and outcomes

  • Method: Use validated CEP68 antibodies for immunohistochemistry on paraffin-embedded tissues

These applications leverage the role of CEP68 in maintaining genomic stability and proper cell division, processes frequently disrupted in cancer cells.

What are common issues with CEP68 antibody specificity and how can they be addressed?

When working with CEP68 antibodies, researchers may encounter several specificity issues:

• Multiple Bands in Western Blot:

  • Expected observation: Two bands of ~90 kDa (CEP68L) and ~67 kDa (CEP68S)

  • Solution: Verify band identity through overexpression of tagged CEP68 isoforms

  • Validation: siRNA-mediated depletion should reduce or eliminate specific bands

• Background Staining in Immunofluorescence:

  • Issue: Non-specific cytoplasmic staining

  • Solution: Optimize antibody concentration (typically 1 μg/ml for affinity-purified antibodies)

  • Validation: Include pre-immune serum controls and siRNA-depleted samples

• Epitope Masking During Cell Cycle:

  • Issue: Loss of signal in mitotic cells may be due to epitope masking rather than protein degradation

  • Solution: Use multiple antibodies targeting different epitopes

  • Validation: Confirm with Western blot analysis of synchronized cell populations

• Species Cross-Reactivity:

  • Issue: Antibody may show differential reactivity across species

  • Solution: Validate antibodies specifically for your model organism

  • Validation: Compare results with published data on CEP68 localization patterns

These strategies ensure reliable and specific detection of CEP68 in various experimental contexts.

How can I reconstitute and store CEP68 antibodies for optimal performance?

For optimal performance of CEP68 antibodies:

• Reconstitution:

  • For lyophilized antibodies, reconstitute with 0.2 mL of distilled water to yield a concentration of 500 μg/mL

  • Allow the reconstituted antibody to sit at room temperature for 5-10 minutes before gentle mixing

  • Avoid vigorous vortexing which may denature the antibody

• Storage Conditions:

  • Store unopened antibody at -20°C

  • After reconstitution, prepare small aliquots to avoid repeated freeze-thaw cycles

  • For short-term use (up to one month), store at 4°C

  • For long-term storage, keep at -20°C or -80°C

• Working Solutions:

  • For immunofluorescence: Dilute to 1-5 μg/mL in 3% BSA-PBS

  • For Western blot: Typically use 0.2-1 μg/mL in 5% non-fat milk or BSA in TBST

  • Prepare fresh working solutions for each experiment

• Quality Control:

  • Periodically validate antibody performance using positive controls

  • Include pre-immune serum controls when possible

  • Monitor for changes in staining patterns or intensity over time

Following these guidelines will help maintain antibody integrity and ensure consistent experimental results.